11 completed, 4 terminated, 2 withdrawn, 1 recruiting. 7 Phase 2, 5 Phase 1, 5 Phase 3, 3 Not applicable, 2 Phase 4.
Follow Oxandrolone: new trials by email Literature Review of Oxandrolone trials Research Report on Oxandrolone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Subdermal Implant-bioabsorbable Oxandrolone Pellet For Rehabilitation Following Anterior Cruciate Ligament (ACL) Surgical Reconstruction Oxandrolone, Placebo - Anterior Cruciate Ligament (ACL) Reconstruction | Phase 2 | Recruiting | Science Valley Research Institute | 96 | 2025-11-28 | 2026-08-25 |
| Oxandrolone Multiligament Knee Oxandrolone, Placebo - Ligament Tear Knee | Phase 4 | Suspended | George F. Hatch | 60 | 2023-07-01 | 2026-03-27 |
| Placebo Versus Oxandrolone Supplementation in Trauma Oxandrolone, Placebo - Trauma Injury | Phase 3 | Withdrawn | Sunnybrook Health Sciences Centre | 2022-05-19 | 2023-08-14 | |
| Use of Oxandrolone to Promote Growth in Infants With HLHS Oxandrolone - Hypoplastic Left Heart, Congenital Heart Disease | Phase 1 / Phase 2 | Terminated | Carelon Research | 34 | 2019-12-20 | 2024-05-23 |
| Oxandrolone Rotator Cuff Trial Oxandrolone, Placebo - Rotator Cuff Tear | Not applicable | Terminated | University of Southern California | 4 | 2018-09-23 | 2026-05-07 |
| Oxandrolone in Healthy Adults: A Relative Bioavailability Study Oxandrin - Bioavailability | Phase 1 | Completed | University of Utah | 6 | 2017-07-10 | 2018-05-03 |
| RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone Iron sucrose, Oxandrolone, IV iron placebo - Functional Iron Deficiency, Trauma | Phase 2 | Withdrawn | Denver Health and Hospital Authority | 2015-01-01 | 2019-04-03 | |
| Pilot Study of the Safety and Efficacy of Oxandrolone in the Prevention and Treatment of Malnutrition in Infants Oxandrolone - Malnutrition | Phase 1 | Completed | University of Utah | 20 | 2010-07-01 | 2020-01-29 |
| Oxandrolone to Heal Pressure Ulcers Oxandrolone, Placebo - Pressure Ulcer | Phase 3 | Terminated | US Department of Veterans Affairs | 212 | 2005-08-01 | 2013-12-20 |
| Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions Oxandrolone, Oxandrin - To Determine the Bioequivalence Under Fasting Conditions | Phase 1 | Completed | Par Pharmaceutical, Inc. | 26 | 2005-03-01 | 2008-04-04 |
| Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia Oxandrolone - Fanconi Anemia | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 10 | 2004-07-01 | 2011-07-15 |
| Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer Megestrol Acetate, Oxandrolone 20 mg - Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes | Phase 3 | Completed | Wake Forest University Health Sciences | 155 | 2004-03-01 | 2021-09-09 |
| Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation Stable Isotope Infusion Study, Collection of blood and tissues, Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI - Burns | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 1126 | 2004-01-01 | 2019-11-29 |
| The Use of Anabolic Steroids to Improve Function After Spinal Cord Injury Oxandrolone - Spinal Cord Injury | Not applicable | Completed | US Department of Veterans Affairs | 40 | 2004-01-01 | 2008-02-13 |
| Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD) Albuterol, Oxandrolone - Muscular Dystrophies | Not applicable | Completed | FDA Office of Orphan Products Development | 160 | 2001-09-01 | 2015-03-25 |
| Assessment of Mechanisms of Improved Wound Healing Stable Isotope Infusion study, Insulin High Dose, oxandrolone - Burns | Phase 2 / Phase 3 | Completed | The University of Texas Medical Branch, Galveston | 644 | 2000-07-01 | 2023-07-03 |
| Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome growth hormone, oxandrolone - Turner's Syndrome | Phase 2 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 80 | 1999-10-01 | 2008-09-10 |
| Nutrition Intervention in AIDS Wasting oxandrolone, Progressive Resistance Training - HIV Wasting Syndrome | Phase 4 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1998-01-01 | 2010-01-13 | |
| The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome Humatrope, Oxandrolone - Dwarfism, Turner's Syndrome | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 80 | 1992-12-11 | 2017-07-02 |
Burns (2) · Motor Activity (2) · Turner Syndrome (2) · Accidental Injuries (1) · Anemia (1) · Body Weight Changes (1) · Dwarfism (1) · Fanconi Anemia (1) · Fasting (1) · Genetic Diseases, Inborn (1) · HIV Wasting Syndrome (1) · Heart Defects, Congenital (1) · Hypoplastic Left Heart Syndrome (1) · Malnutrition (1) · Muscle Weakness (1)
The University of Texas Medical Branch, Galveston (2) · US Department of Veterans Affairs (2) · University of Utah (2) · Carelon Research (1) · Children's Hospital Medical Center, Cincinnati (1) · Denver Health and Hospital Authority (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · FDA Office of Orphan Products Development (1) · George F. Hatch (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Par Pharmaceutical, Inc. (1) · Science Valley Research Institute (1) · Sunnybrook Health Sciences Centre (1) · University of Southern California (1)
United States (17) · Brazil (1) · Canada (1) · Puerto Rico (1)
Phillip T Burch, MD (2) · Abby Shevitz, MD (1) · David N Herndon, MD (1) · David N. Herndon, MD (1) · Eduardo Ramacciotti, MD, PhD (1) · Edward G. Shaw, MD (1) · Franklin O Smith, M.D. (1) · Fredric M Pieracci, MD, MPH (1) · George Hatch, MD (1) · George R Hatch, MD (1) · Glenn J. Lesser, MD (1) · John T. Kissel, M.D. (1) · Judith L Ross (1) · Kresimir Banovac, PhD MD (1)
PMID 22606232, PMID 18791359, PMID 19240154, PMID 19734776, PMID 20395554, PMID 20701787, PMID 20739853, PMID 20881067, PMID 21789167, PMID 22463890, PMID 22895351, PMID 23150682, PMID 23303450, PMID 23511841, PMID 23689765, PMID 24009246, PMID 24298851, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25514427, PMID 25807408, PMID 27171844, PMID 27433905, PMID 28240622, PMID 36656551
P50GM060338 (2), R01GM056687 (1), U10CA081851 (1)